Article
Purkinje cell loss in experimental autoimmune encephalomyelitis.
Laboratory of Neuro Imaging, Suite 225, Los Angeles, CA 90095-1769, USA.
NeuroImage (impact factor:
5.89).
08/2009;
48(4):637-51.
DOI:10.1016/j.neuroimage.2009.06.073
pp.637-51
Source: PubMed
- Citations (2)
-
Cited In (0)
-
Article: Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.
[show abstract] [hide abstract]
ABSTRACT: We assessed axonal loss in the normal appearing white matter of the corpus callosum in postmortem brains of patients with multiple sclerosis, using quantitative measures of both axonal density and white matter atrophy. The calculated total number of axons was reduced significantly (mean +/- SD, 5.4 x 10(7) +/- 3.1 x 10(7)) compared with normal controls (11.6 x 10(7) +/- 2.2 x 10(7), p = 0.001) with a reduction both in axonal density (median, 34%; range, 16-56%; p = 0.004) and area (mean +/- SD: multiple sclerosis, 584 +/- 170 mm2; controls, 871 +/- 163 mm2; p = 0.004). These results confirm substantial axonal loss in the normal appearing white matter and demonstrate that measures of both axonal density and white matter volume are necessary to appreciate the full extent of axonal loss.Annals of Neurology 04/2000; 47(3):391-5. · 11.09 Impact Factor -
Article: Endocytosis: why not wait to deubiquitinate?
[show abstract] [hide abstract]
ABSTRACT: Deubiquitination by the Fat facets protein - a regulator of photoreceptor differentiation during Drosophila eye development - has been found to activate endocytosis, while ubiquitination inhibits endocytosis. Surprisingly, this is the opposite effect that ubiquitination has on endocytosis of many plasma membrane proteins.Current Biology 08/2000; 10(14):R532-4. · 9.65 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
Anatomical delineations
cerebellar cortex
clinical disability
Cross modality
disease duration
EAE mice
experimental autoimmune encephalomyelitis
gray matter atrophy
multiple sclerosis
neurodegenerative disease
neuropathology approaches
population atlasing
post-mortem high-resolution T2-weighted magnetic resonance microscopy
pro-apoptotic marker caspase-3
Purkinje cell loss
Purkinje cell number
significant association
significant decrease
stained magnetic resonance histology images
underlying neuropathology